Gómez-Ríos N, Vargas-Trujillo C, Fernández-Rivera BJ

Language: Spanish
References: 7
Page: 366-369
PDF size: 771.59 Kb.

Text Extraction

No abstract.

REFERENCES

1. Arias-Rivera S, Raurell-Torredá M, Moro-Tejedor MN, Thuissard-Vasallo IJ, Andreu-Vázquez C, Frutos-Vivar F. Validez y sensibilidad alcambio de la Clinical Frailty Scale-España en pacientes ingresados encuidados intensivos. Enferm Intensiva. 2025;36:500558. doi: 10.1016/j.enfi.2025.500558.

2. Shehata N, Whitlock R, Fergusson DA, Thorpe KE, MacAdams C,Grocott HP, et al. Transfusion Requirements in Cardiac Surgery III(TRICS III): study design of a randomized controlled trial. J CardiothoracVasc Anesth. 2018;32:121-129. doi: 10.1053/j.jvca.2017.10.036.

3. Dabic P, Petrovic J, Vucurevic B, Sevkovic M, Pesic S, Neskovic M,et al. Major adverse cardiac events in vascular surgery patients withperipheral arterial disease. Medicinska istrazivanja. 2024;57:9-13. doi:10.5937/medi57-47260.

4. Kougias P, Sharath SE, Zhan M, Carson JL, Norman LE, Mi Z, et al.Liberal or restrictive postoperative transfusion in patients at high cardiacrisk: the TOP randomized clinical trial. JAMA. 2025;334:2197-2207.doi: 10.1001/jama.2025.20841.

5. Carson JL, Brooks MM, Hébert PC, Goodman SG, Bertolet M, GlynnSA, et al. Restrictive or liberal transfusion strategy in myocardialinfarction and anemia. N Engl J Med. 2023;389:2446-2456. doi: 10.1056/NEJMoa2307983.

6. Petrovic J, Pesic S, Davidovac N, Jelicic D, Stojanovic S, Neskovic M,et al. Preoperative anemia and coronary artery disease as predictors ofmajor adverse cardiac events after open abdominal aortic surgery. J ClinMed. 2026;15:738. doi: 10.3390/jcm15020738.

7. Chen S, Xu L, Liu S, Ren B, Zhang Y, Chong J, et al. Nationwideexpert survey on transfusion and coagulation management strategiesfor bleeding critically ill patients in China. J Crit Care 2026;92:155352.doi: 10.1016/j.jcrc.2025.155352.